Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CTAGE1
REST API REST API
Homo sapiens
CTAGE1 is differentially expressed in 61 experiments: 53 organism parts: dorsal root ganglion, trigeminal ganglion, ... (51 more);, 68 disease states: normal, Emery-Dreifuss muscular dystrophy, ... (66 more);, 14 cell types 36 cell lines 10 compound treatments and 35 other conditions.
Synonyms CTAGE, CT21.1, CT21.2, cTAGE-1, cTAGE-2
Orthologs D3ZHI1_RAT (Rattus norvegicus)   ENSGALG00000010189 (Gallus gallus)   ctage5 (Danio rerio)   Ctage5 (Mus musculus)   Tango1 (Drosophila melanogaster)   ctage5 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term membrane, biological_process, cellular_component, integral to membrane
UniProt Accession Q96RT6, Q8NEG8
Search EB-eye ENSG00000212710
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-2665, E-AFMX-5, E-GEOD-15765, E-MTAB-24, E-MTAB-25, ... (10 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-22639, E-TABM-420, E-GEOD-2450, E-GEOD-19480, E-MEXP-440, ... (6 experiments)

Factor Value U/D Experiments
KS-IMM
1
E-MTAB-62
NA18504
1
E-GEOD-19480
NCU-MM1
1
E-MTAB-62
mcf10a-myc cells
1
E-MTAB-62
caco-2
1
E-MTAB-62
HCC1143
1
E-MTAB-62
30 more value(s).


Cell type

studied in E-AFMX-5, E-GEOD-6691, E-MTAB-24, E-MTAB-25, E-GEOD-3920, ... (7 experiments)

Factor Value U/D Experiments
plasma cell
1
E-GEOD-6691
germ cell
1
E-MTAB-25
endothelial cell
1
E-GEOD-3920
leydig cell
1
E-MTAB-25
BDCA4+ dentritic cells
1
E-AFMX-5
B lymphocyte
1
E-GEOD-6691
8 more value(s).


Disease state

studied in E-GEOD-14895, E-GEOD-3307, E-GEOD-5418, E-GEOD-3167, E-GEOD-25932, ... (12 experiments)

Factor Value U/D Experiments
follicular thyroid carcinoma
1
E-MTAB-62
non-ischemic cardiomyopathy
1
E-GEOD-1869
nephrosclerosis
1
E-GEOD-20602
cancer
1
E-GEOD-25932
dermatomyositis
1
E-GEOD-5370
myocardial infarction
1
E-MTAB-62
62 more value(s).


Compound treatment

studied in E-MEXP-1269, E-GEOD-5258, E-GEOD-3284, E-GEOD-5824, E-GEOD-3113, ... (6 experiments)

Factor Value U/D Experiments
ponasterone A
1
E-GEOD-3113
rapamycin
1
E-GEOD-5824
bacterial endotoxin
1
E-GEOD-3284
none
38
1
E-GEOD-5824
monastrol
1
E-GEOD-5258
ethanol
1
E-GEOD-3113
4 more value(s).


BioSourceProvider

studied in E-GEOD-19480

Factor Value U/D Experiments
Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=NA18504
1
E-GEOD-19480
Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=NA19193
1
E-GEOD-19480


Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

Developmental stage
studied in E-GEOD-2666, E-MTAB-62

Environmental stress
studied in E-GEOD-1518

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Individual
studied in E-GEOD-2322, E-MTAB-197, E-GEOD-3284, E-GEOD-974, E-MEXP-455, ... (11 experiments)

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-MEXP-958

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801

Performer
studied in E-GEOD-2004, E-LGCL-5

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-1343

sampleID
studied in E-GEOD-24283

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4271, E-GEOD-4922

Processing time: 0.804 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM